Back to available technologies

Adenoviral delivery of innate immune stimulatory molecules for cancer therapy

The invention generally relates to compositions and methods for preventing and treating cancer. More specifically, the invention relates to MAVS compositions and their use in cancer therapeutics that may be used to treat various cancers alone or in combination with other anti-cancer therapeutic agents.

Duke File (IDF) Number

T-005014

Inventor(s)

  • Hartman, Zachary
  • Lyerly, Herbert "Kim"

For more information please contact

College

School of Medicine (SOM)

Interested in this Technology?

Submit your interest below.